financetom
Business
financetom
/
Business
/
Chevron says zinc levels in U.S. Mars oil output within limits
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Chevron says zinc levels in U.S. Mars oil output within limits
Jul 23, 2025 8:21 AM

HOUSTON (Reuters) -Chevron on Tuesday said recent testing indicates that zinc levels in flagship U.S. offshore crude Mars' production stream were now within expected levels. 

The start-up of an offshore well caused zinc contamination in Mars crude, Chevron had said earlier this month, leading to  tightening crude oil supply in the key Gulf Coast refining hub and the government releasing barrels from its emergency stockpile.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Biohaven Shares Rise on Drug Pipeline Update With Two Near-Market Candidates
Biohaven Shares Rise on Drug Pipeline Update With Two Near-Market Candidates
Jun 4, 2025
01:47 PM EDT, 06/04/2025 (MT Newswires) -- Biohaven ( BHVN ) shares were up over 4% in recent trading on Wednesday after the company said its two drug candidates are near market and it is doing phase three testing for four other indications. BHV-4157 for the treatment of spinocerebellar ataxia and BHV-2000 for spinal muscular atrophy are closer to the...
Moleculin Biotech Shares Slump After Phase 1b/2 Trial of Annamycin Fails to Show Complete Responses
Moleculin Biotech Shares Slump After Phase 1b/2 Trial of Annamycin Fails to Show Complete Responses
Jun 4, 2025
01:50 PM EDT, 06/04/2025 (MT Newswires) -- Moleculin Biotech ( MBRX ) shares dropped about 19% in recent Wednesday trading after the company said no patients achieved complete response in the phase 1b/2 study of Annamycin for the treatment of soft tissue sarcoma lung metastases, a type of cancer. The trial, however, demonstrated a clinical benefit rate of 59.4%, primarily...
Newly-Listed Sionna Therapeutics Touts Positive Data From Lung Disease Candidate In Healthy Volunteer Trial
Newly-Listed Sionna Therapeutics Touts Positive Data From Lung Disease Candidate In Healthy Volunteer Trial
Jun 4, 2025
Sionna Therapeutics, Inc. ( SION ) released data from its Phase 1 trials of SION-719 and SION-451, the company’s first-in-class nucleotide-binding domain 1 (NBD1) stabilizers, in healthy volunteers. One hundred subjects were dosed in the SION-719 trial, and 110 subjects were dosed in the SION-451 trial. Data Highlights Both NBD1 stabilizers were generally well tolerated and achieved pharmacokinetic (PK) concentration...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved